European Archives - Page 1159 of 1193 - European Medical Journal

EMJ

Introduction to the Burden of Recurrent Cystitis and Rationale for Prevention

This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology…

EMJ

Recurrent Urinary Tract Infections: Can Immunoactive Prophylaxis Improve Disease Management In Healthy Women?

This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology from…

EMJ

Urinary Tract Infection in Specific Populations and Controversies in Disease Management

The physiological and anatomical changes associated with pathological and non-pathological conditions, such as pregnancy, can modify both the risk…

EMJ

Infecciones urinarias recurrentes: ¿puede la profilaxis inmunoactiva mejorar el tratamiento de la enfermedad en mujeres sanas?

Resumen de las presentaciones seleccionadas de la cumbre OM Pharma/Vifor Pharma URO-VAXOM® celebrada en Buenos Aires (Argentina) los días 26 y 27…

EMJ

EMJ Urology 1 [Suppl 3] 2014

Esta cumbre, de carácter educativo y financiada por una beca independiente de OM/Vifor Pharma, ha reunido a expertos en urología y ginecología…

EMJ

EMJ Urology 1 [Suppl 2] 2014

This education summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology from…

EMJ

Experts Call for Greater Awareness of Alcohol Related Liver Disease and Liver Cancer

Vienna, 24 November 2014 – United European Gastroenterology (UEG) is supporting the second annual Awareness Week on Alcohol Related Harm (AWARH)

EMJ

High-Dose Interleukin-2 Effective in Metastatic Renal Cell Cancer Pre-Treated with VEGF-Targeted Therapies

Lugano/Geneva, Switzerland, 24 November 2014 – High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated…

Optimising the Patient Journey in Chronic Spontaneous Urticaria

Summary of Presentations from the Novartis-Supported Satellite Symposium, held at the 23rd EADV Congress, Amsterdam, on 9th October 2014

Revealing a Clear Path Towards a New Era in the Management of Psoriasis

The meeting provided a bench-to-bedside overview of the targeting of interleukin-17 (IL-17) for the treatment of psoriasis.